NHLBI Innovation Research Grant for Assays to Measure Personal Risk for Cardiovascular Disease
February 28, 2014
CytoVas, a biomarker and diagnostics company founded by Department faculty members Jonni S. Moore, PhD, and Wade Rogers, PhD, as well as Professor of Medicine Emile Mohler, MD has received a Phase I Small Business Innovation Research Grant (SBIR) from the National Heart, Lung and Blood Institute (NHLBI) for the development of cellular assays that would be commercialized as in-vitro diagnostics for the measurement of the personal risk for cardiovascular disease. The company is currently conducting a number of clinical studies developing cell- and particle-based flow cytometry tests for evaluating the health of the cardiovascular system. CytoVas was also recently featured at American Heart Association's Scientific Sessions Meeting in Dallas as the first recipient of the AHA's Science & Technology Accelerator Program support.